ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $155,499,000 | +60.2% | 8,244,896 | 0.0% | 5.20% | +89.5% |
| Q2 2019 | $97,042,000 | -13.8% | 8,244,896 | 0.0% | 2.75% | -16.6% |
| Q1 2019 | $112,543,000 | +68.8% | 8,244,896 | +26.7% | 3.29% | +22.8% |
| Q4 2018 | $66,684,000 | -38.4% | 6,505,766 | 0.0% | 2.68% | -19.5% |
| Q3 2018 | $108,321,000 | +5.4% | 6,505,766 | 0.0% | 3.33% | -4.6% |
| Q2 2018 | $102,791,000 | +24.4% | 6,505,766 | 0.0% | 3.49% | +9.5% |
| Q1 2018 | $82,623,000 | +10.9% | 6,505,766 | 0.0% | 3.19% | -1.5% |
| Q4 2017 | $74,491,000 | -6.1% | 6,505,766 | +0.4% | 3.24% | -17.3% |
| Q3 2017 | $79,340,000 | +211.6% | 6,476,766 | +191.2% | 3.91% | +152.5% |
| Q2 2017 | $25,463,000 | -35.9% | 2,223,811 | +16.4% | 1.55% | -39.9% |
| Q1 2017 | $39,726,000 | +107.5% | 1,909,886 | +107.5% | 2.58% | +56.2% |
| Q4 2016 | $19,147,000 | -16.8% | 920,550 | +31.0% | 1.65% | -9.9% |
| Q3 2016 | $23,022,000 | – | 702,539 | – | 1.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |